Typically, a screening diagnosis of Lynch Syndrome is made on a pathology specimen after surgery for bowel or uterine cancer. Confirmation of Lynch Syndrome requires a genetic testing.
Patients who are negative for Lynch Syndrome/2 have the “normal” risk of uterine and bowel cancer similar to the general population. The only exemption would be if patients carry a specific mutation that has not been described yet.
Patients with Lynch syndrome will benefit from prophylactic, risk-reducing removal of uterus, tubes and ovaries. Prophylactic surgery can mostly be done laparoscopically
